4.4 Article

Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells

Journal

ANTI-CANCER DRUGS
Volume 12, Issue 5, Pages 475-483

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001813-200106000-00009

Keywords

cytotoxicity drug screening; digitalis glycosides; digitonin; digitoxigenin; digitoxin; digoxin; lanatoside C; ouabain; proscillaridin A; tumor cell lines

Ask authors/readers for more resources

The saponin digitonin, the aglycone digitoxigenin and five cardiac glycosides were evaluated for cytotoxicity using primary cultures of tumor cells from patients and a human cell line panel (representing different cytotoxic drug-resistance patterns). Of these seven compounds, proscillaridin A was the most potent (IC50: 6.4-76 nM), followed by digitoxin, and then ouabain, digoxin, lanatoside C, digitoxigenin and digitonin, Correlation analysis of the log IC50 values for the cell lines in the panel showed that compound cytotoxicity was only slightly influenced by resistance mechanisms that involved P-glycoprotein, topoisomerase II, multidrug resistance-associated protein and glutathione-mediated drug resistance. Digitoxin and digoxin expressed selective toxicity against solid tumor cells from patients, while proscillaridin A expressed no selective toxicity against either solid or hematological tumor cells. The results revealed marked differences in cytotoxicity between the cardiac glycosides, both in potency and selectivity, and modes of action for cytotoxicity that differ from that of commonly used anticancer drugs. [(C) 2001 Lippincott Williams & Wilkins.].

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available